mRNA vaccine

2 Drugs classified under this drug class

mRNA vaccine. tozinameran 180 mcg/multidose vial.
Multidose vial for dilution: One dil. dose (0.3 mL) contains 30 micrograms of tozinameran. Admin. sec. dose 3 weeks after first.
Active immunisation against SARS-CoV-2 virus, in 12 years of age and older.
C/I:Hypersens.

mRNA vaccine. tozinameran 180 mcg/multidose vial.
Multidose vial 6X 0.3 ml, each dose cont. 30 mcg tozinameran.
To be admin. IM as a course of 2 doses, 3 weeks apart.
Act. immun. against SARS- Cov-2 vir. in 12 years old and above.
C/I: Hypersens.